Clinical Trials | April 15, 2025
Dr. Lal PathLabs becomes South Asia's first to launch advanced test for amyloidosis
More than 40 types of Amyloid proteins are discovered till date
More than 40 types of Amyloid proteins are discovered till date
Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older
The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
The company expects to launch this product through its marketing partner in the near future
Subscribe To Our Newsletter & Stay Updated
